Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China - 14/02/22
Doi : 10.1016/j.jinf.2021.12.020
Bo Xu 1, a, Fu-qiang Ma 1, a, Cong He 1, b, Zi-qi Wu c, Cun-yu Fan d, He-rong Mao a, Ji-xian Zhang d, ⁎ 
, Min Yang a, ⁎ , Zuo-wei Hu e, ⁎
, Min Yang a, ⁎ , Zuo-wei Hu e, ⁎ a Hubei University Of Chinese Medicine, Wuhan 430065, China
b Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, China, Affiliated Hospital of Hubei University of Traditional Chinese Medicine, Wuhan, 430061, China, Hubei Province Academy of Traditional Chinese Medicine, Wuhan, 430074, China
c Wuhan University Of Science And Technology, Wuhan 430081, China,Maternal and Child Health Hospital of Hubei Province, Tongji Medical College,Huazhong University of Science and Technology, 430070, China
d Hubei Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Wuhan 430015, China
e Wuhan No.1 Hospital,Hubei University of Chinese Medicine Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, No. 215, Zhongshan Avenue, Qiaokou District, Wuhan, Hubei 430022, China
⁎Corresponding authors.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
Plan
© 2021
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 84 - N° 2
P. e16-e18 - février 2022 Retour au numéro
Article précédent
- Impact of non-pharmaceutical interventions during COVID-19 pandemic on pertussis, scarlet fever and hand-foot-mouth disease in China
- Yiman Geng, Leiliang Zhang
- Genetic variation of interleukin-1 receptor type 1 is associated with severity of COVID-19 disease
- Renxi Wang
Bienvenue sur EM-consulte, la référence des professionnels de santé.